Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4f7l | 0SO | Cyclin-dependent kinase 8 | 2.7.11.22 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4f7l | 0SO | Cyclin-dependent kinase 8 | 2.7.11.22 | 1.000 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.495 | |
4f6w | 0SS | Cyclin-dependent kinase 8 | 2.7.11.22 | 0.491 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.473 | |
3s1c | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.465 | |
2q8s | L92 | Peroxisome proliferator-activated receptor gamma | / | 0.464 | |
2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.459 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.459 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
1t86 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.458 | |
3eej | 53R | Uncharacterized protein | / | 0.458 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.457 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
3rps | 4B0 | Casein kinase II subunit alpha | 2.7.11.1 | 0.457 | |
1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.456 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.454 | |
1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.453 | |
3r3f | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.452 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
1ojt | FAD | Dihydrolipoyl dehydrogenase | / | 0.449 | |
3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
3aty | FMN | Prostaglandin F2a synthase | / | 0.448 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.448 | |
1b38 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1ykr | 628 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4fki | 09K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.447 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.446 | |
3r34 | COA | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.446 | |
3t2z | FAD | Sulfide-quinone reductase | / | 0.446 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
1cqp | 803 | Integrin alpha-L | / | 0.445 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.445 | |
3mdm | FJZ | Cholesterol 24-hydroxylase | / | 0.445 | |
4b4o | NDP | Epimerase family protein SDR39U1 | / | 0.445 | |
4zoh | FAD | Putative oxidoreductase FAD-binding subunit | / | 0.445 | |
2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3kjs | DQ1 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.444 | |
3of2 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
3q9w | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.443 | |
1nzf | UPG | DNA beta-glucosyltransferase | / | 0.443 | |
1t1r | IMB | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.443 | |
1x2h | LPA | Lipoate-protein ligase A | 6.3.1.20 | 0.443 | |
2eq6 | FAD | Dihydrolipoyl dehydrogenase | / | 0.443 | |
3icr | COA | Coenzyme A disulfide reductase | / | 0.443 | |
3ics | COA | Coenzyme A disulfide reductase | / | 0.443 | |
3r37 | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.443 | |
4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4ge4 | 0KE | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.443 | |
4ix5 | ANP | Uncharacterized protein | / | 0.443 | |
4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
1dz6 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
1qmf | KEF | Penicillin-binding protein 2x | / | 0.442 | |
3gwf | FAD | Cyclohexanone monooxygenase | / | 0.442 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.442 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.442 | |
3r3c | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.442 | |
4h50 | NAP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.442 | |
4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.441 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.441 | |
3r7i | X9I | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.441 | |
4lxh | C1E | Alpha/beta hydrolase fold | / | 0.441 | |
4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.441 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
1lp4 | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
1q1r | FAD | Putidaredoxin reductase | 1.18.1.5 | 0.440 | |
2gn8 | NAP | UDP-N-acetylglucosamine 4,6-dehydratase (inverting) | 4.2.1.115 | 0.440 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.440 | |
2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.440 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.440 | |
3vjh | J35 | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.440 | |
4ix6 | ADP | Uncharacterized protein | / | 0.440 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.440 |